Fernandes FB. Major evidence of the GLP-1 analog (liraglutide) in the treatment of obesity: a systematic review. IJN [Internet]. 2023 Apr. 19 [cited 2024 Apr. 30];16(2). Available from: https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/285